Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women
about
The alliance of mesenchymal stem cells, bone, and diabetesIsolation and characterization of human osteoblasts from needle biopsies without in vitro culture.Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing.Acute decline in serum sclerostin in response to PTH infusion in healthy men.Global transcriptional profiling using RNA sequencing and DNA methylation patterns in highly enriched mesenchymal cells from young versus elderly women.Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selectionA DNA binding mutation in estrogen receptor-α leads to suppression of Wnt signaling via β-catenin destabilization in osteoblasts.Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls.Examination of ERα signaling pathways in bone of mutant mouse models reveals the importance of ERE-dependent signalingThe molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosisChanges in bone sclerostin levels in mice after ovariectomy vary independently of changes in serum sclerostin levelsNovel adipokines and bone metabolism.Deletion of Estrogen Receptor Beta in Osteoprogenitor Cells Increases Trabecular but Not Cortical Bone Mass in Female Mice.Inhibition of Pref-1 (preadipocyte factor 1) by oestradiol in adolescent girls with anorexia nervosa is associated with improvement in lumbar bone mineral densitySclerostin and bone strength in women in their 10th decade of life.Sclerostin and Pref-1 have differential effects on bone mineral density and strength parameters in adolescent athletes compared with non-athletes.The Important Role of Osteoblasts and Citrate Production in Bone Formation: "Osteoblast Citration" as a New Concept for an Old Relationship.Pathogenesis of age-related bone loss in humansIdentification of Rorβ targets in cultured osteoblasts and in human bone.Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humansEffects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women.The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity.The bone and fat connection in inflammatory bowel diseases.Regulation of Bone Metabolism by Sex Steroids.Hormonal and systemic regulation of sclerostin.Exploiting the WNT Signaling Pathway for Clinical Purposes.Osteoprotection Through the Deletion of the Transcription Factor Rorβ in Mice.Serum serotonin levels and bone in rheumatoid arthritis patients.The relationship between circulating adiponectin, leptin and vaspin with bone mineral density (BMD), arterial calcification and stiffness: a cross-sectional study in post-menopausal women.Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab
P2860
Q27012497-4AC558B0-61E2-44BD-8286-37701C9E0B9CQ34437408-810A2050-EB16-4933-B4C8-37F280599201Q35158918-4216377F-719F-421D-B8CF-9753F0434A7EQ35498077-33E5F47C-CA02-44CD-AD02-DB3BAB1BE7C9Q35660938-E30632A6-06F3-46D9-BB9A-064784A96B3EQ35754233-A5D1B3CE-3E41-414E-B2BF-3957C32BA8F7Q35952286-F643E947-2F85-466C-81FF-CA075D9F55C0Q36143916-A2864710-5BFF-4FA6-9476-397B44FA5694Q36323192-317FC1C8-B9C2-4F47-A43D-E4C67868FC6CQ36553435-3C075FD3-B954-46F7-B62D-252079D64390Q36561855-22242EBC-A62F-418A-9073-3C4115C72E93Q36619316-6413E3D3-29C5-4817-A826-7EFFAA00B168Q36769843-EF15A67E-32B7-401E-97B2-5BEE1E35BAC6Q36807580-2512A1B8-C739-43FE-80E5-E0D40CC4176CQ37045961-DE77DC49-FACD-494E-9894-5E743EAE4C95Q37086296-EBD91419-35B4-4FCD-ABDC-D8ACBD0E33A4Q37274467-AC45A830-D929-4B56-8A4E-C45DDB3A7516Q37305810-201F20F4-B146-423A-9B68-9F151971BC96Q37377722-82227F0A-3CD3-4D8C-80D6-DA033B4FD17BQ37423382-D80067BD-1F37-4938-8D61-A496546CE17DQ37428990-CA3D4E4E-553A-4216-A5F8-353C8D9EB7D2Q38062322-18FEC96A-C3DF-41E1-AD59-341871ECA524Q38225220-04999D35-5818-41B2-891B-BFA8F85119C3Q38657323-042ADA84-D0A4-4B94-8164-B6A415735EE4Q39037907-A6294B0A-FAAF-4C93-9F39-17C61F9E5AF7Q39255803-F2A4ED24-0B26-40EB-8BE8-C017625887CEQ47329687-CE120209-F9C5-48FE-A879-DC845F9FFF18Q47831726-8D4916A7-673F-4954-8679-3386C7FFF1F4Q51262365-63897FDE-6316-4165-A066-554E5513900AQ58903538-30429DF1-3FDF-498C-AAA0-3C7C3211308C
P2860
Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effects of estrogen on osteopr ...... actors in postmenopausal women
@ast
Effects of estrogen on osteopr ...... actors in postmenopausal women
@en
type
label
Effects of estrogen on osteopr ...... actors in postmenopausal women
@ast
Effects of estrogen on osteopr ...... actors in postmenopausal women
@en
prefLabel
Effects of estrogen on osteopr ...... actors in postmenopausal women
@ast
Effects of estrogen on osteopr ...... actors in postmenopausal women
@en
P2093
P2860
P1433
P1476
Effects of estrogen on osteopr ...... actors in postmenopausal women
@en
P2093
David G Monroe
James M Peterson
Kelley Hoey
Louise K McCready
Matthew M Roforth
Merry Jo Oursler
Sundeep Khosla
Ulrike I Mödder
P2860
P304
P356
10.1016/J.BONE.2011.04.015
P577
2011-04-29T00:00:00Z